These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6408349)

  • 1. Frequency determination of killer cells by a single-cell cytotoxic assay.
    Bonavida B; Bradley TP; Grimm EA
    Methods Enzymol; 1983; 93():270-80. PubMed ID: 6408349
    [No Abstract]   [Full Text] [Related]  

  • 2. Human spontaneous killer cells selective for tumour-derived target cells.
    Jondal M; Spine C; Targan S
    Nature; 1978 Mar; 272(5648):62-4. PubMed ID: 305005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of the cytotoxic effect of tumor cells against the targets of normal killers].
    Fuks BB; Zedginidze MS; Spirande IV; Kogarko IN; Sterlina AG
    Biull Eksp Biol Med; 1981 Sep; 92(9):342-5. PubMed ID: 7295991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of natural cytotoxicity by alloantibodies. V. The mechanism of a selective augmenting effect of anti-H-2 antisera on the natural killer activity of mouse spleen cells.
    Saxena RK; Saxena QB; Adler WH
    Cell Immunol; 1981 Nov; 65(1):115-30. PubMed ID: 6797740
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
    Igarashi T; Okada M; Kishimoto T; Yamamura Y
    J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
    Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
    J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G
    J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural killers and macrophages: their activity in leukemias].
    Fi FT
    Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945
    [No Abstract]   [Full Text] [Related]  

  • 9. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumor host cells of experimental rat neoplasms: characterization and effector function.
    Moore M; Moore K
    Contemp Top Immunobiol; 1980; 10():109-42. PubMed ID: 6967795
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.
    Hancock EJ; Kilburn DG
    Cancer Immunol Immunother; 1982; 14(1):54-8. PubMed ID: 6819082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of P815 mastocytoma cells with inhibitors of protein synthesis reduces their susceptibility to lysis by cytotoxic thymus-derived lymphocytes.
    D'Angeac AD; Hale AH
    Cell Immunol; 1980 Oct; 55(2):342-54. PubMed ID: 6775821
    [No Abstract]   [Full Text] [Related]  

  • 13. Poly-L-lysine-induced immobilization of tumor cells to plastic for the study of cellular metabolic responses to attack by cytotoxic T lymphocytes.
    Sepulveda CA; Schlager SI
    Methods Enzymol; 1983; 93():260-70. PubMed ID: 6408348
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic reactivity of lymphoid cells in tumors.
    Herberman RB; Holden HT; Varesio L; Taniyama T; Puccetti P; Kirchner H; Gerson J; White S; Keisari Y; Haskill JS
    Contemp Top Immunobiol; 1980; 10():61-78. PubMed ID: 6967800
    [No Abstract]   [Full Text] [Related]  

  • 15. A new model for leukemia-lymphoma metastasis: differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow.
    Kamenov B; Kieran MW; Leigh JB; Greenberg AH; Longenecker BM
    Symp Fundam Cancer Res; 1983; 36():245-64. PubMed ID: 6679093
    [No Abstract]   [Full Text] [Related]  

  • 16. Enucleated target cells are susceptible to lymphocyte-mediated cytolysis.
    Court WS; Lindquist RR
    Transplantation; 1979 Oct; 28(4):351-3. PubMed ID: 116402
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of specific suppressor cells with heat-treated allogeneic tumor cells.
    Chiu KM; Faanes RB; Choi YS
    Cell Immunol; 1980 Feb; 49(2):283-92. PubMed ID: 6444368
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.
    Pross HF; Baines MG
    Int J Cancer; 1976 Nov; 18(5):593-604. PubMed ID: 825477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 20. Augmentation of natural cell-mediated cytotoxic reactivity of mouse lymphoid cells by aloctin A.
    Imanishi K; Suzuki I
    Int J Immunopharmacol; 1984; 6(5):539-43. PubMed ID: 6437994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.